HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression

Human Immunology

Volumn 61, Issue 11, 2000, Pages 1177-1195

  Paul, Pascale ^a   Rouas Freiss, Nathalie ^a   Moreau, Philippe ^a   Cabestre, Francisco Adrian ^a   Menier, Catherine ^a   Khalil Daher, Iman ^a   Pangault, Céline ^b   Onno, Myriam ^b   Fauchet, Renée ^b   Martinez Laso, Jorge ^c   Morales, Pablo ^c   Villena, Antonio Arnaiz ^c   Giacomini, Patrizio ^d   Natali, Pier Giorgio ^d   Frumento, Guido ^e   Ferrara, Giovan Battista ^e   McMaster, Michael ^f   Fisher, Susan ^f   Schust, Danny ^g   Ferrone, Soldano ^h   Dausset, Jean ⁱ   Geraghty, Dan ^j   Carosella, Edgardo D ^a   more..

^a Inst Univ d'Hématologie   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ Fondation Jean Dausset   (France)

^j Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

HLA G monoclonal antibodies; HLA G, F, E transcription; Non classical HLA class I genes

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; CONFERENCE PAPER; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IMMUNOMODULATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; CELL LINE; FLOW CYTOMETRY; GENE EXPRESSION; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0034502325     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00154-3     Document Type: Conference Paper

References (51)

1. A tolerance molecule from the major histocompatibility complex
2. The functionality of HLA-G is emerging
3. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
4. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissues
5. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
6. Nonclassical HLA-G molecules are classical peptide presenters
7. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
8. Functions of nonclassical MHC and non-MHC-encoded class I molecules
9. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
10. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
11. HLA-F is a predominantly empty, intracellular, TAP-associated MHC Class Ib protein with a restricted expression pattern
12. Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes
13. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4
14. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens
15. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
16. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts
17. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
18. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA-G) bind to peripheral blood myelomonocytic cells
19. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
20. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
21. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the Ig superfamily
22. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
23. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
24. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
25. Recognition of human histocompatibility leucocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
26. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
27. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself
28. HLA-G mediated-inhibition of antigen-specific cytotoxic T lymphocytes
29. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts
30. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody
31. Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells
32. Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody
33. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts
34. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
35. The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G
36. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation
37. HLA-G expression during preimplantation human embryo development
38. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ
39. HLA-G class I gene expression in normal and malignant hematopoietic cells
40. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
41. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
42. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
43. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
44. HLA-G protein expression is not induced during malignant transformation
45. Implication of HLA-G molecule in heart graft acceptance
46. Evidence for the expression of non-HLA-A,-B-C class I genes in the human fetal liver
47. Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term
48. Lack of HLA-G soluble isoformes in Graves-Basedow thyrocytes and complete cDNA sequence of the HLA-G*01012 allele
49. Detection of HLA-E and -G alleles for population and disease studies
50. Single step method of RNA isolotion by acid guanidinium thiocyanate phenol chloroforme extraction
51. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines